Equity Profile

CRON

Cronos Group Inc.

Health CarePharmaceuticals$1.0B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Cronos Group Inc. is a healthcare company focused on the production and sale of cannabis products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help investors gauge financial health this quarter.

N/A

Revenue Growth

Revenue growth is crucial for understanding how well the company is expanding its market presence and meeting consumer demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CRON Q2-2026 Earnings Preview

Context

Company Snapshot

Cronos Group Inc. is a healthcare company focused on the production and sale of cannabis products. As a player in the pharmaceuticals industry, it is part of a growing market that is increasingly recognized for its potential therapeutic benefits.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+173.81%

Avg Stock Reaction

+7.89%

Last Quarter Recap

In Q1-2026, Cronos Group reported an EPS of $0.04, significantly exceeding expectations of $0.01, leading to an 8.27% increase in stock price the following day. However, revenue figures were not disclosed.

Management Promises & Guidance

Focus on expanding product lines.
Enhancing distribution channels.
Commitment to improving operational efficiency.

Expectations

Wall Street Expectations

Overall, expectations are mixed as there are no analyst estimates available, making it difficult to gauge market sentiment. Investors will be closely watching for any surprises in earnings and revenue.

Bull Case

If Cronos Group continues its trend of beating EPS estimates, it could see significant stock price appreciation, especially given its recent performance.

Bear Case

Conversely, if the company fails to meet expectations or if revenue growth stalls, it may lead to a negative reaction in the stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and a strong figure could boost investor confidence.

How is revenue growth tracking compared to previous quarters?

Understanding revenue growth will provide insights into the company's market performance and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cronos Group's ability to maintain its recent earnings momentum despite the lack of analyst estimates.

Supporting Evidence

The company has consistently surprised on EPS in recent quarters, indicating strong operational performance.

Options are pricing a 33.86% move, suggesting traders expect significant volatility that may not be reflected in consensus views.

Key Risk

If EPS comes in above $0.05, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on whether Cronos can sustain its recent earnings momentum and show solid revenue growth.

Bull Confirmed If

An EPS of $0.05 or higher would confirm strong profitability and growth.

Bear Confirmed If

An EPS below $0.01 would indicate potential struggles in maintaining profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±33.86%

Historical Avg

±7.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±33.9% while CRON has averaged ±7.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

43.7%

Calls (101K)P/C Ratio: 0.08Puts (8K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cronos beats expectations, history suggests a potential stock increase of around 10.37%, confirming positive momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further clarity.

Miss

A miss could lead to a decline of approximately 7.48%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product line expansions.
2Details on revenue growth strategies.
3Insights into market share changes.
4Management's outlook on operational efficiency improvements.
5Any commentary on competitive positioning in the cannabis market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Cronos Group Inc. is a healthcare company focused on the production and sale of cannabis products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help investors gauge financial health this quarter.

N/A

Revenue Growth

Revenue growth is crucial for understanding how well the company is expanding its market presence and meeting consumer demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CRON Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+173.81%

Avg Stock Reaction

+7.89%

Last Quarter Recap

Management Promises & Guidance

Focus on expanding product lines.
Enhancing distribution channels.
Commitment to improving operational efficiency.

Expectations

Wall Street Expectations

Bull Case

If Cronos Group continues its trend of beating EPS estimates, it could see significant stock price appreciation, especially given its recent performance.

Bear Case

Conversely, if the company fails to meet expectations or if revenue growth stalls, it may lead to a negative reaction in the stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and a strong figure could boost investor confidence.

How is revenue growth tracking compared to previous quarters?

Understanding revenue growth will provide insights into the company's market performance and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cronos Group's ability to maintain its recent earnings momentum despite the lack of analyst estimates.

Supporting Evidence

The company has consistently surprised on EPS in recent quarters, indicating strong operational performance.

Options are pricing a 33.86% move, suggesting traders expect significant volatility that may not be reflected in consensus views.

Key Risk

If EPS comes in above $0.05, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on whether Cronos can sustain its recent earnings momentum and show solid revenue growth.

Bull Confirmed If

An EPS of $0.05 or higher would confirm strong profitability and growth.

Bear Confirmed If

An EPS below $0.01 would indicate potential struggles in maintaining profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±33.86%

Historical Avg

±7.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±33.9% while CRON has averaged ±7.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

43.7%

Calls (101K)P/C Ratio: 0.08Puts (8K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cronos beats expectations, history suggests a potential stock increase of around 10.37%, confirming positive momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further clarity.

Miss

A miss could lead to a decline of approximately 7.48%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product line expansions.
2Details on revenue growth strategies.
3Insights into market share changes.
4Management's outlook on operational efficiency improvements.
5Any commentary on competitive positioning in the cannabis market.